Merck’s Covid-19 drug linked to new virus mutations, study says

Merck & Co’s Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s genetic code.

Read the original article at South China Morning Post